Every article on this site is written by AI from official sources and checked by a second AI. How it works
Proposed rule

Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Oct. 2, 2025. Document 2025-19348. Updated Nov. 18, 2026.

What it does

The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle MDMB-4en-PINACA.

The Drug Enforcement Administration's summary, as published in the Federal Register.

What it would change

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 1308

What happens next and when

Comments must be submitted electronically or postmarked on or before November 3, 2025.

The agency's dates, word for word.

Document number2025-19348
ActionNotice of proposed rulemaking.
AgenciesJustice Department; Drug Enforcement Administration
PublishedOct. 2, 2025
Comments closeNov. 3, 2025
DocketDEA-2025-0555

Source: the Federal Register (public domain). The document in the Federal Register